Fellowship · New York, NY
Sponsored by New York Presbyterian Hospital
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Liora Schultz
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
The New England journal of medicine · 2024 · 351 citations · Monica Bhatia
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature · 2025 · 172 citations · Liora Schultz
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Nature medicine · 2021 · 534 citations · Liora Schultz
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 212 citations · Liora Schultz, Prakash Satwani
Tumor inflammation-associated neurotoxicity.
Nature medicine · 2023 · 143 citations ·
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 138 citations · Maria Sulis
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation.
Seminars in thrombosis and hemostasis · 2024 · 32 citations · Cindy Neunert